The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this effort.
The overarching goal of this project grant is to advance medical solutions for the treatment of peripheral nerve injuries, a common battlefield trauma. The research will focus on developing innovative bioactive nerve graft technologies to promote peripheral nerve regeneration. Findings from this work have the potential to significantly improve clinical outcomes and care for military service members as well as the broader patient population affected by peripheral nerve damage.
Generated 11/26/24, 1:31 AM